Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers.

MLA

Karu, Naama, et al. “Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers.” Metabolites, vol. 12, no. 7, July 2022. EBSCOhost, https://doi.org/10.3390/metabo12070619.

APA

Karu, N., Kindt, A., Lamont, L., van Gammeren, A. J., Ermens, A. A. M., Harms, A. C., Portengen, L., Vermeulen, R. C. H., Dik, W. A., Langerak, A. W., van der Velden, V. H. J., & Hankemeier, T. (2022). Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers. Metabolites, 12(7). https://doi.org/10.3390/metabo12070619

Chicago

Karu, Naama, Alida Kindt, Lieke Lamont, Adriaan J van Gammeren, Anton A M Ermens, Amy C Harms, Lutzen Portengen, et al. 2022. “Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers.” Metabolites 12 (7). doi:10.3390/metabo12070619.